Whole transcriptome analysis of breast cancer tumors during neoadjuvant chemotherapy: association with hematogenous metastasis

The assessment of molecular genetic landscape changes during NAC and the relationship between molecular signatures in residual tumors are promising approaches for identifying effective markers of outcome in breast cancer. The majority of the data in the literature present the relationship between th...

Полное описание

Библиографическая информация
Опубликовано в: :International journal of molecular sciences Vol. 23, № 22. P. 13906 (1-14)
Главный автор: Ibragimova, Marina K.
Другие авторы: Tsyganov, Matvey M., Litvyakov, Nicolay V.
Формат: Статья в журнале
Язык:English
Предметы:
Online-ссылка:http://vital.lib.tsu.ru/vital/access/manager/Repository/koha:001008790
Перейти в каталог НБ ТГУ
LEADER 03382nab a2200361 c 4500
001 koha001008790
005 20240124174224.0
007 cr |
008 231026|2022 sz s a eng d
024 7 |a 10.3390/ijms232213906  |2 doi 
035 |a koha001008790 
040 |a RU-ToGU  |b rus  |c RU-ToGU 
100 1 |a Ibragimova, Marina K.  |9 101505 
245 1 0 |a Whole transcriptome analysis of breast cancer tumors during neoadjuvant chemotherapy: association with hematogenous metastasis  |c M. K. Ibragimova, M. M. Tsyganov, N. V. Litvyakov 
336 |a Текст 
337 |a электронный 
504 |a Библиогр.: 22 назв. 
520 3 |a The assessment of molecular genetic landscape changes during NAC and the relationship between molecular signatures in residual tumors are promising approaches for identifying effective markers of outcome in breast cancer. The majority of the data in the literature present the relationship between the molecular genetic landscape and the response to NAC or are simply descriptive. The present study aimed to determine changes in expression profiles during NAC and assess the relationship between gene expression and the outcome of patients with luminal B HER2 breast cancer depending on distant hematogenous metastasis. The study included 39 patients with luminal B HER2-BC. The patients received 6-8 courses of NAC, and paired samples consisting of biopsy and surgical materials were analyzed. A full transcriptome microarray analysis was performed using the human Clariom™ S Assay platform (Affymetrix, 3450 Central Expy, Santa Clara, CA, 95051, USA). A comparison of the expression profiles of patients with breast cancer before and after NAC, depending on the status of hematogenous metastasis, was conducted. It was shown that the amount of DEGs in the tumor was reduced by more than six times after NAC. The top 10 signaling pathways were also found, the activity of which varied depending on the status of hematogenous metastasis before and after NAC. In addition, the association of DEGs with hematogenous metastasis in patients with breast cancer was evaluated: MFS was assessed depending on the expression level of 21 genes. It was shown that MFS was significantly associated with the expression level and pattern of nine genes. The expression levels of nine DEGs in the tumors of patients with breast cancer after NAC were significantly correlated with MFS when the status of hematogenous metastasis was taken into account. 
653 |a рак молочной железы 
653 |a неоадъювантная химиотерапия 
653 |a полный анализ транскриптома 
653 |a профиль экспрессии опухоли 
653 |a гематогенные метастазы 
655 4 |a статьи в журналах  |9 897718 
700 1 |a Tsyganov, Matvey M.  |9 219371 
700 1 |a Litvyakov, Nicolay V.  |9 101564 
773 0 |t International journal of molecular sciences  |d 2022  |g Vol. 23, № 22. P. 13906 (1-14)  |x 1661-6596 
852 4 |a RU-ToGU 
856 4 |u http://vital.lib.tsu.ru/vital/access/manager/Repository/koha:001008790 
856 |y Перейти в каталог НБ ТГУ  |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=1008790 
908 |a статья 
999 |c 1008790  |d 1008790 
039 |b 100